CHENGDU ZHIPA QINGRUN TRADING CO., LTD. – Trademark Portfolio

Entity Type: 99

CHENGDU ZHIPA QINGRUN TRADING CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include COLIKES. The owner is based in CHENGDU, SICHUAN.

NO. 2724, 2/F, NO. 1, WULIDUN BRANCH

CHENGDU, SICHUAN 610000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

COLIKES
COLIKES
Registered 2020

Trademark Classifications

CHENGDU ZHIPA QINGRUN TRADING CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does CHENGDU ZHIPA QINGRUN TRADING CO., LTD. have?

CHENGDU ZHIPA QINGRUN TRADING CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does CHENGDU ZHIPA QINGRUN TRADING CO., LTD. file in?

CHENGDU ZHIPA QINGRUN TRADING CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are CHENGDU ZHIPA QINGRUN TRADING CO., LTD.'s most well-known trademarks?

CHENGDU ZHIPA QINGRUN TRADING CO., LTD.'s registered trademark portfolio includes well-known marks such as COLIKES. These are among 1 currently registered trademark in the portfolio.

What is CHENGDU ZHIPA QINGRUN TRADING CO., LTD.'s trademark registration success rate?

CHENGDU ZHIPA QINGRUN TRADING CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.